Preexposure prophylaxis with antiretroviral drugs has been effective in the prevention of human immunodeficiency virus (HIV) infection in some trials but not in others
BACKGROUND : As oral pre-exposure prophylaxis (PrEP) becomes the standard of prevention globally, it...
Worldwide, nearly 5 million new HIV infections occurred in 2005 with more than 3 million of these in...
The impressive advances in antiretroviral (ARV) therapy of chronic human immunodeficiency virus (HIV...
Preexposure prophylaxis with antiretroviral drugs has been effective in the prevention of human immu...
BACKGROUND: Preexposure prophylaxis with antiretroviral drugs has been effective in the prevention o...
According to 3 field trials conducted in Africa, one among African women and two among heterosexual ...
The early closure of a clinical trial assessing the effectiveness of oral antiretroviral pre-exposur...
In 2017, Kenya became one of the first African countries to provide pre-exposure prophylaxis (PrEP) ...
HIV incidence remains high among young women in sub-Saharan Africa in spite of scale-up of HIV testi...
The Southern African HIV Clinicians Society published its first set of oral pre-exposure prophylaxis...
ObjectiveTo evaluate preexposure prophylaxis (PrEP) efficacy for HIV-1 prevention among women using ...
Background: HIV incidence in adolescent girls and young women remains high in sub-Saharan Africa. Pr...
Morbidity and mortality weekly report. 2012 Aug 10;61(31):586-9.In the United States, an estimated 4...
Since the beginning of the United States AIDS epidemic in the early 1980s, the medical community has...
infections per year in the United States, we need more effective HIV prevention strategies. The use ...
BACKGROUND : As oral pre-exposure prophylaxis (PrEP) becomes the standard of prevention globally, it...
Worldwide, nearly 5 million new HIV infections occurred in 2005 with more than 3 million of these in...
The impressive advances in antiretroviral (ARV) therapy of chronic human immunodeficiency virus (HIV...
Preexposure prophylaxis with antiretroviral drugs has been effective in the prevention of human immu...
BACKGROUND: Preexposure prophylaxis with antiretroviral drugs has been effective in the prevention o...
According to 3 field trials conducted in Africa, one among African women and two among heterosexual ...
The early closure of a clinical trial assessing the effectiveness of oral antiretroviral pre-exposur...
In 2017, Kenya became one of the first African countries to provide pre-exposure prophylaxis (PrEP) ...
HIV incidence remains high among young women in sub-Saharan Africa in spite of scale-up of HIV testi...
The Southern African HIV Clinicians Society published its first set of oral pre-exposure prophylaxis...
ObjectiveTo evaluate preexposure prophylaxis (PrEP) efficacy for HIV-1 prevention among women using ...
Background: HIV incidence in adolescent girls and young women remains high in sub-Saharan Africa. Pr...
Morbidity and mortality weekly report. 2012 Aug 10;61(31):586-9.In the United States, an estimated 4...
Since the beginning of the United States AIDS epidemic in the early 1980s, the medical community has...
infections per year in the United States, we need more effective HIV prevention strategies. The use ...
BACKGROUND : As oral pre-exposure prophylaxis (PrEP) becomes the standard of prevention globally, it...
Worldwide, nearly 5 million new HIV infections occurred in 2005 with more than 3 million of these in...
The impressive advances in antiretroviral (ARV) therapy of chronic human immunodeficiency virus (HIV...